Dr. Mahesh Padmanaban's primary clinical interest is in movement disorders, which includes tremor, dystonia, hemifacial spasm, blepharospasm, tics and Tourette's syndrome, chorea and Huntington's disease, Parkinson's disease (PD), Lewy Body Dementia (LBD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and cortical basal ganglionic degeneration (CBGD). His treatment methods include the use of medications, botulinum toxin injections and deep brain stimulation (DBS) surgery when applicable for the treatment of these neurological conditions.
The University of Chicago
IL
Fellowship - Movement Disorders
Northwestern University
IL
Fellowship - Movement Disorders
The University of Chicago
IL
Residency
West Virginia University
WV
Internship
West Virginia University
WV
M.D.
Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's disease.
Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's disease. Parkinsonism Relat Disord. 2025 Nov; 140:108057.
PMID: 40986940
The Natural History Study and Biomarker Collection of the Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA).
The Natural History Study and Biomarker Collection of the Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA). Cerebellum. 2025 Jul 18; 24(5):134.
PMID: 40679685
Bedside Assessment of Downgaze Limit by Amplitude.
Bedside Assessment of Downgaze Limit by Amplitude. Mov Disord Clin Pract. 2025 Dec; 12(12):2224-2231.
PMID: 40641209
Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patients.
Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patients. Parkinsonism Relat Disord. 2025 Sep; 138:107951.
PMID: 40651129
The Spectrum of Neurologic Phenotypes Associated With NUS1 Pathogenic Variants: A Comprehensive Case Series.
The Spectrum of Neurologic Phenotypes Associated With NUS1 Pathogenic Variants: A Comprehensive Case Series. Ann Neurol. 2025 Sep; 98(3):561-572.
PMID: 40590478
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations. medRxiv. 2025 Jan 20.
PMID: 39867380
The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocol.
The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocol. BMC Neurol. 2024 Oct 21; 24(1):403.
PMID: 39434044
Cognitive outcomes in patients with essential tremor treated with deep brain stimulation: a systematic review.
Cognitive outcomes in patients with essential tremor treated with deep brain stimulation: a systematic review. Front Hum Neurosci. 2024; 18:1319520.
PMID: 38371461
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study. Lancet Neurol. 2023 11; 22(11):1015-1025.
PMID: 37633302
Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations.
Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations. medRxiv. 2023 May 07.
PMID: 37398408